Efficacy of the antagonists serotonine receptors in nausea and vomiting non related with antineoplastic chemotherapy and resistents to usual treatment;Eficacia de los antagonistas de la serotonina en las náuseas y vómitos no relacionados con quimioterapia antineoplásica y resistentes al tratamiento habitual

Medicina Paliativa

Volumn 7, Issue 2, 2000, Pages 62-66

  Tuca, A ^a   Porta, J ^a   Porcel, J M ^a   Salut, E ^a   Sala, C ^a   Trelis, J ^a   Gomez Batiste X ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Antagonists serotonine receptors; Antiemetics; Granisetron; Nausea; Ondansetron; Palliative Care; Vomiting

Indexed keywords

GRANISETRON; ONDANSETRON;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; DISEASE CONTROL; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; MULTICENTER STUDY; PALLIATIVE THERAPY; RETROSPECTIVE STUDY; VOMITING;

EID: 0034490651     PISSN: 1134248X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Chronic nausea in advanced cancer patients: A retrospective assessment of a metoclopramide-based antiemetic regimen
2. Nauseas and vomiting
3. Results of antiemetic management in terminal illness
4. Síntomas gastrointestinales, obstrucción intestinal
5. Antiemetic efficacy of high-dose metoclopramide: Randomized trials with prochlorperazine in patients with chemoterpy induced nausea and vomiting
6. Inhibition of cisplatin-induced vomiting byselective 5-hidroxytryptamine M-receptor antagonism
7. 3 receptor antagonism as antiemetic agents
8. Clinical pharmacokinetics of ondansetron
9. 3 receptors in mammalian hindbrain
10. Selective and functional 5-hydroxytryptamine receptor antagonism by BRL 43694 (granisetron)
11. 3 receptor antagonist, in healthy male volunteers
12. Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy and surgery
13. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications
14. Subcutaneous ondansetron
15. Ondansetron by subcutaneous infusion
16. Ondansetron in intractable nausea and vomiting
17. Successfully control of intractable nausea and vomiting requiring combined ondansetron and haloperidol in a patient with advanced cancer
18. Use of ondansetron in palliative medicine
19. Ondansetron in nausea and vomiting induced by spinal morphine
20. Ondansetron: Pre-clinical safety evaluation